I henhold til ” CHMP Guideline on Risk Management Systems for medicinal products for human use ” skal den opdaterede RMP indsendes samtidig med næste Periodic Safety Update Report (PSUR).
As per the CHMP Guideline on Risk Management Systems for medicinal products for human use, the updated RMP should be submitted at the same time as the next Periodic Safety Update Report (PSUR).